147 related articles for article (PubMed ID: 8484635)
1. The effects of combined histamine and platelet-activating factor antagonism on systemic anaphylaxis induced by immunoglobulin E in the rabbit.
Lohman IC; Halonen M
Am Rev Respir Dis; 1993 May; 147(5):1223-8. PubMed ID: 8484635
[TBL] [Abstract][Full Text] [Related]
2. Effects of the PAF antagonist WEB 2086 on PAF-induced physiologic alterations and on IgE anaphylaxis in the rabbit.
Lohman I; Halonen M
Am Rev Respir Dis; 1990 Aug; 142(2):390-7. PubMed ID: 2382903
[TBL] [Abstract][Full Text] [Related]
3. Characterization of cardiovascular events mediated by platelet activating factor during systemic anaphylaxis.
Felix SB; Baumann G; Hashemi T; Niemczyk M; Ahmad Z; Berdel WE
J Cardiovasc Pharmacol; 1990 Jun; 15(6):987-97. PubMed ID: 1694923
[TBL] [Abstract][Full Text] [Related]
4. Participation of platelets in the physiologic alterations of the AGEPC response and of IgE anaphylaxis in the rabbit. Effects of PGI2 inhibition of platelet function.
Halonen M; Lohman IC; Dunn AM; McManus LM; Palmer JD
Am Rev Respir Dis; 1985 Jan; 131(1):11-7. PubMed ID: 3881060
[TBL] [Abstract][Full Text] [Related]
5. The role of histamine in the physiologic alterations of IgE anaphylaxis in the rabbit.
Halonen M; Lohman IC; Palmer JD
Immunopharmacology; 1984 Apr; 7(2):77-87. PubMed ID: 6724878
[TBL] [Abstract][Full Text] [Related]
6. Inhibitor effect of apafant on bronchopulmonary responses to platelet activating factor and to antigen in rats.
Akagi M; Nishioka E; Kanoh R; Tachibana M; Fukuishi N
Arzneimittelforschung; 1997 Dec; 47(12):1364-9. PubMed ID: 9450165
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of platelet depletion on the physiologic alterations of IgE anaphylaxis and acetyl glyceryl ether phosphorylcholine infusion in the rabbit.
Halonen M; Palmer JD; Lohman IC; McManus LM; Pinckard RN
Am Rev Respir Dis; 1981 Oct; 124(4):416-21. PubMed ID: 7294504
[TBL] [Abstract][Full Text] [Related]
8. Mouse anaphylactic shock is caused by reduced cardiac output, but not by systemic vasodilatation or pulmonary vasoconstriction, via PAF and histamine.
Wang M; Shibamoto T; Tanida M; Kuda Y; Kurata Y
Life Sci; 2014 Oct; 116(2):98-105. PubMed ID: 25252221
[TBL] [Abstract][Full Text] [Related]
9. The responses of pulmonary and systemic circulation and airway to anaphylactic mediators in anesthetized BALB/c mice.
Wang M; Shibamoto T; Kuda Y; Tanida M; Zhang T; Song J; Kurata Y
Life Sci; 2016 Feb; 147():77-84. PubMed ID: 26808090
[TBL] [Abstract][Full Text] [Related]
10. Modulation of antigen- and ischemia-induced effects by the platelet-activating factor antagonist WEB-2086 in isolated sensitized rat hearts.
Vleeming W; Wemer J; Porsius AJ
J Cardiovasc Pharmacol; 1992; 20(5):790-9. PubMed ID: 1280743
[TBL] [Abstract][Full Text] [Related]
11. Platelet-activating factor (Paf) antagonist, WEB 2086, protects against Paf-induced hypotension in Macaca fascicularis.
Stanton AW; Izumi T; Antoniw JW; Piper PJ
Br J Pharmacol; 1989 Jul; 97(3):643-6. PubMed ID: 2758235
[TBL] [Abstract][Full Text] [Related]
12. Histamine, leukotriene D4 and platelet-activating factor in guinea pig passive cutaneous anaphylaxis.
Weg VB; Watson ML; Cordeiro RS; Williams TJ
Eur J Pharmacol; 1991 Nov; 204(2):157-63. PubMed ID: 1687219
[TBL] [Abstract][Full Text] [Related]
13. Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF).
Merlos M; Giral M; Balsa D; Ferrando R; Queralt M; Puigdemont A; García-Rafanell J; Forn J
J Pharmacol Exp Ther; 1997 Jan; 280(1):114-21. PubMed ID: 8996188
[TBL] [Abstract][Full Text] [Related]
14. Immunoglobulin E anaphylaxis in rabbits: mechanisms of pulmonary resistance and compliance changes.
Habib MP; Dunn AM; Sobonya RE; Baumgartener CC; Newell JD; Halonen M
J Appl Physiol (1985); 1988 Mar; 64(3):1009-16. PubMed ID: 3366724
[TBL] [Abstract][Full Text] [Related]
15. Respiratory and circulatory alterations induced by acetyl glyceryl ether phosphorylcholine, a mediator of IgE anaphylaxis in the rabbit.
Halonen M; Palmer JD; Lohman IC; McManus LM; Pinckard RN
Am Rev Respir Dis; 1980 Dec; 122(6):915-24. PubMed ID: 7458063
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular responses to exogenous platelet-activating factor (PAF) in anesthetized ponies, and the effects of a PAF antagonist, WEB 2086.
Wilson DV; Eberhart SW; Robinson NE; Rice R; Gray PR
Am J Vet Res; 1993 Feb; 54(2):274-9. PubMed ID: 8430938
[TBL] [Abstract][Full Text] [Related]
17. Platelet activating factor-induced microvascular permeability increases in the cat hindlimb.
Lu Z; Wolf MB
Circ Shock; 1993 Sep; 41(1):8-18. PubMed ID: 8403248
[TBL] [Abstract][Full Text] [Related]
18. Platelet activating factor and histamine effects in synovial blood flow evaluated by laser-Doppler flowmetry.
Rocha FA; Jancar S; Fraga CA; Timo-Iaria C; De Brum-Fernandes AJ
J Rheumatol; 1993 Aug; 20(8):1374-7. PubMed ID: 8230022
[TBL] [Abstract][Full Text] [Related]
19. Beneficial effects of TCV-309, a novel potent and selective platelet activating factor antagonist in endotoxin and anaphylactic shock in rodents.
Terashita Z; Kawamura M; Takatani M; Tsushima S; Imura Y; Nishikawa K
J Pharmacol Exp Ther; 1992 Feb; 260(2):748-55. PubMed ID: 1738121
[TBL] [Abstract][Full Text] [Related]
20. PAF, rather than histamine, participates in mouse anaphylactic hypotension.
Shibamoto T; Liu W; Cui S; Zhang W; Takano H; Kurata Y
Pharmacology; 2008; 82(2):114-20. PubMed ID: 18583921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
